ANDA 214370

NORWICH

FDA Drug Application

Application #214370

Application Sponsors

ANDA 214370

NORWICH

Marketing Status

• None (Tentative Approval): 001

Application Products

001

TABLET;ORAL

200MG

0

RIFAXIMIN

RIFAXIMIN

FDA Submissions

UNKNOWN;

ORIG

1

TA

2022-09-02

STANDARD

Submissions Property Types

ORIG

1

Null

31

CDER Filings

NORWICH

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214370
            [companyName] => NORWICH
            [docInserts] => ["",""]
            [products] => [{"drugName":"RIFAXIMIN","activeIngredients":"RIFAXIMIN","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/02\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-09-02
        )

)